Compatibility of selected drugs with pediatric parenteral nutrition solutions during simulated Y-site administration;Kompatibilnost odabranih lijekova s pedljatruskim otopinama za parenteralnu prehranu prilikom simulirane istodobne primjene putem Y-mjesta

Paediatria Croatica

Volumn 50, Issue 4, 2006, Pages 179-185

  Puzović, Marko ^a,b   Kukec Jerković, Martina ^a  

^a Odsjek za Parenteralnu Prehranu ^*  (Croatia)

^b Hrvatski Zavod za Transfuzijsku Medicinu   (Croatia)

Author keywords

Drug incompatibility; Parenteral nutrition; Pharmaceutical solutions chemistry, administration and dosage

Indexed keywords

AMINOPHYLLINE; CEFTRIAXONE; DEXAMETHASONE; MIDAZOLAM; RANITIDINE;

ARTICLE; PARENTERAL NUTRITION;

EID: 33947594958     PISSN: 13301403     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gikic M, Di Paolo ER, Pannatier A, Cotting J. Evaluation of physicochemical incompatibilities during parenteral drug administration in a paediatric intensive care unit. Pharm World Sci 2000;22:88-91.
2. Vogel Kahmann I, Burki R, Denzler U, Hofler A, Schmid B, Splisgardt H. Inkompatibilitätsreaktionen auf der Intensivstation. Fünf Jahre nach Einführung einer einfachen Farbkodierung. Anaesthesist 2003; 52:409-12.
3. Hardy G, Messing B. Beyond the bag horizon. Nutrition 2005; 21:1179-80.
4. Trissel LA. Handbook on injectable drugs. Bethesda, MD: American Society of Health-System Pharmacists, 1996.
5. Hill SE, Heldman LS, Goo ED, Whippo PE, Perkinson JC. Fatal microvascular pulmonary emboli from precipitation of a total nutrient admixture solution. JPEN J Parenter Enteral Nutr 1996;20:81-7.
6. Lumpkin MM. Safety alert: hazards of precipitation associated with parenteral nutrition. Am J Health Syst Pharm 1994; 51:1427-28.
7. Veltri M, Lee CK. Compatibility of neonatal parenteral nutrient solutions with selected intravenous drugs. Am J Health Syst Pharm 1996;53:2611-13.
8. Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM. Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration. Am J Health Syst Pharm 1997;54:1295-300.
9. Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM. Compatibility of medications with 3-in-1 parenteral nutrition admixtures. JPEN J Parenter Enteral Nutr 1999;23:67-74.
10. Smith G. Incompatibility. In: Lund W, Bichan M, eds. The Pharmaceutical Codex, Principles and Practice of Pharmaceutics. 12th ed. London: Royal Pharmaceutical Society of Great Britain, 1994;311-21.
11. Thomson FC, Naysmith MR, Lindsay A. Managing drug therapy in patients receiving enteral and parenteral nutrition. Hosp Pharm 2000;7:155-64.
12. Raupp P, von Kries R, Pfahl HG, Manz F. Glycero- vs glucose-phosphate in parenteral nutrition of premature infants: a comparative in vitro evaluation of calcium/phosphorus compatibility. JPEN J Parenter Enteral Nutr 1991; 15:469-73.
13. Ronchera-oms CL, All wood MC, Hardy G. Organic phosphates in parenteral nutrition: pouring fresh water into an old bucket. Nutrition 1996;12:388-9.
14. Ball P. Principles for formulating parenteral nutrition for neonates. Curr Opin Clin Nutr Metab Care 1999; 2:261-4.
15. Gura KM, Puder M. Recent developments in aluminium contamination of products used in parenteral nutrition. Curr Opin Clin Nutr Metab Care 2006;9:239-46.
16. Popinska K, Kierkus J, Lyszkowska M. Aluminum contamination of parenteral nutrition additives, amino acid solutions, and lipid emulsions. Nutrition 1999; 15:683-6.
17. Henry RS, Jurgens Rw, Jr., Sturgeon R, Athanikar N, Welco A, Van Leuven M. Compatibility of calcium chloride and calcium gluconate with sodium phosphate in a mixed TPN solution. Am J Health Syst Pharm 1980;37:673-74.
18. Kirkpatrick AE, Holcombe BJ, Sawyer WT. Effect of retrograde aminophylline administration on calcium and phosphate solubility in neonatal total parenteral nutrient solutions. Am J Health Syst Pharm 1989;46:2496-500.
19. Schmidt GL, Baumgartner TG, Fischlschweiger W, Sitren HS, Thakker KM, Cerda JJ. Cost containment using cysteine HCl acidification to increase calcium/phosphate solubility in hyperalimentation solutions. JPEN J Parenter Enteral Nutr 1986;10:203-7.
20. Mirtallo JM. Complications associated with drug and nutrient interactions. J Infus Nurs 2004;27:19-24.
21. Cosslett AG, Price R. Stability of drug additions to parenteral nutrition (PN) admixtures (Abstracts). Clinical Nutrition 2004; 23:935.
22. Ball PA. Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care 2003;6:319-25.
23. Leff RD, Roberts RJ. Practical aspects of intravenous drug administration: principles and techniques for nurses, pharmacists, and physicians. Bethesda, MD: American Society of Hospital Pharmacists, 1992.
24. Nieuwoudt CD. Dilution of intravenous medications for neonates. Am J Health Syst Pharm 1995;52:1320-2.